Home > Products > IL13 & IL4 > Human Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG)

Human Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG)  (BSIG-H337)

Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-IL13 and anti-IL4 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.

Specifications

Targets
IL13 & IL4
Type
IgG-IgG
Species Reactivity
Human
Target 1
IL13
Host Animal 1
Human
Target 2
IL4
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Idiopathic pulmonary fibrosis

Targets

Target 1
IL13
Gene ID
UniProt ID
Alternative Names
IL13; interleukin 13; P600; IL-13; interleukin-13
Target 2
IL4
Gene ID
UniProt ID
Alternative Names
IL4; interleukin 4; BSF1; IL-4; BCGF1; BSF-1; BCGF-1; interleukin-4; binetrakin; pitrakinra; B cell growth factor 1; interleukin 4 variant 2; B_cell stimulatory factor 1; lymphocyte stimulatory factor 1

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) (BSIG-H337). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "IL13 & IL4"
See other bsAb targets related to "IL13"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: